Trastuzumab-DM1 causes tumour growth inhibition by mitotic catastrophe in trastuzumab-resistant breast cancer cells in vivo

Overview of attention for article published in Breast Cancer Research, April 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 1 news outlet

patent: 3 patents

Readers on

mendeley: 175 Mendeley

Summary News Patents

So far, Altmetric has seen 3 patents that reference this research output.

Biological materials and uses thereof

Grant US-11202837-B2

United States of America

DIRECT IMMUNOHISTOCHEMISTRY ASSAY

Application EP-3140653-A4

European Patent Office

CONJUGATE OF MONOMETHYL AURISTATIN F AND TRASTUZUMAB AND ITS USE FOR THE TREATMENT OF…

Application WO-2016173682-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.